v3.26.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Common Stock in Treasury
Non- controlling Interest
Common stock, beginning balance (in shares) at Sep. 30, 2024   124,376,000          
Beginning balance at Sep. 30, 2024 $ 191,063 $ 217 $ 1,806,000 $ 4,750 $ (1,625,523) $ 0 $ 5,619
Treasury stock, beginning balance (in shares) at Sep. 30, 2024           0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation 15,209   15,209        
Exercise of stock options (in shares)   70,000          
Exercise of stock options 634   634        
Common stock - restricted stock units vesting (in shares)   209,000          
Issuance of pre-funded warrants 25,000   25,000        
Foreign currency translation adjustments (106)     (106)      
Unrealized gains (losses) on available-for-sale securities, net (507)     (507)      
Net income (loss) (175,218)       (173,085)   (2,133)
Common stock, ending balance (in shares) at Dec. 31, 2024   124,655,000          
Ending balance at Dec. 31, 2024 56,075 $ 217 1,846,843 4,137 (1,798,608) $ 0 3,486
Treasury stock, ending balance (in shares) at Dec. 31, 2024           0  
Common stock, beginning balance (in shares) at Sep. 30, 2024   124,376,000          
Beginning balance at Sep. 30, 2024 191,063 $ 217 1,806,000 4,750 (1,625,523) $ 0 5,619
Treasury stock, beginning balance (in shares) at Sep. 30, 2024           0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Foreign currency translation adjustments (415)            
Unrealized gains (losses) on available-for-sale securities, net 1,022            
Net income (loss) 13,993            
Common stock, ending balance (in shares) at Jun. 30, 2025   138,144,000          
Ending balance at Jun. 30, 2025 519,806 $ 230 2,120,130 5,357 (1,603,404) $ 0 (2,507)
Treasury stock, ending balance (in shares) at Jun. 30, 2025           0  
Common stock, beginning balance (in shares) at Dec. 31, 2024   124,655,000          
Beginning balance at Dec. 31, 2024 56,075 $ 217 1,846,843 4,137 (1,798,608) $ 0 3,486
Treasury stock, beginning balance (in shares) at Dec. 31, 2024           0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation 16,027   16,027        
Exercise of stock options (in shares)   353,000          
Exercise of stock options 2,619   2,619        
Common stock - restricted stock units vesting (in shares)   1,128,000          
Common stock - restricted stock units vesting 1 $ 1          
Issuance of common stock, net of issuance costs (in shares)   11,926,000          
Issuance of common stock, net of issuance costs 241,387 $ 12 241,375        
Foreign currency translation adjustments (400)     (400)      
Unrealized gains (losses) on available-for-sale securities, net 653     653      
Net income (loss) 367,863       370,445   (2,582)
Common stock, ending balance (in shares) at Mar. 31, 2025   138,062,000          
Ending balance at Mar. 31, 2025 684,225 $ 230 2,106,864 4,390 (1,428,163) $ 0 904
Treasury stock, ending balance (in shares) at Mar. 31, 2025           0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation 13,043   13,043        
Exercise of stock options (in shares)   36,000          
Exercise of stock options 223   223        
Common stock - restricted stock units vesting (in shares)   46,000          
Foreign currency translation adjustments 91     91      
Unrealized gains (losses) on available-for-sale securities, net 876     876      
Net income (loss) (178,652)       (175,241)   (3,411)
Common stock, ending balance (in shares) at Jun. 30, 2025   138,144,000          
Ending balance at Jun. 30, 2025 $ 519,806 $ 230 2,120,130 5,357 (1,603,404) $ 0 (2,507)
Treasury stock, ending balance (in shares) at Jun. 30, 2025           0  
Common stock, beginning balance (in shares) at Sep. 30, 2025 135,702,000 138,363,000          
Beginning balance at Sep. 30, 2025 $ 503,416 $ 231 2,139,725 6,443 (1,627,154) $ (53,193) 37,364
Treasury stock, beginning balance (in shares) at Sep. 30, 2025 (2,661,000)         (2,661,000)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation $ 19,371   19,371        
Exercise of stock options (in shares)   296,000          
Exercise of stock options 5,098   5,098        
Common stock - restricted stock units vesting (in shares)   704,000          
Common stock - restricted stock units vesting 2 $ 1 1        
Issuance of common stock, net of issuance costs (in shares)   689,000          
Issuance of common stock, net of issuance costs 46,832 $ 1 46,831        
Foreign currency translation adjustments 110     110      
Unrealized gains (losses) on available-for-sale securities, net 146     146      
Dividends declared by variable interest entity to noncontrolling shareholders (40,520)           (40,520)
Net income (loss) 28,242       30,811   (2,569)
Common stock, ending balance (in shares) at Dec. 31, 2025   140,052,000          
Ending balance at Dec. 31, 2025 $ 562,697 $ 233 2,211,026 6,699 (1,596,343) $ (53,193) (5,725)
Treasury stock, ending balance (in shares) at Dec. 31, 2025           (2,661,000)  
Common stock, beginning balance (in shares) at Sep. 30, 2025 135,702,000 138,363,000          
Beginning balance at Sep. 30, 2025 $ 503,416 $ 231 2,139,725 6,443 (1,627,154) $ (53,193) 37,364
Treasury stock, beginning balance (in shares) at Sep. 30, 2025 (2,661,000)         (2,661,000)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of stock options (in shares) 576,859            
Foreign currency translation adjustments $ 1,588            
Unrealized gains (losses) on available-for-sale securities, net (9,042)            
Net income (loss) $ (288,249)            
Common stock, ending balance (in shares) at Jun. 30, 2026 141,135,000 143,796,000          
Ending balance at Jun. 30, 2026 $ 466,041 $ 237 2,443,074 (1,234) (1,923,355) $ (53,193) 512
Treasury stock, ending balance (in shares) at Jun. 30, 2026 (2,661,000)         (2,661,000)  
Common stock, beginning balance (in shares) at Dec. 31, 2025   140,052,000          
Beginning balance at Dec. 31, 2025 $ 562,697 $ 233 2,211,026 6,699 (1,596,343) $ (53,193) (5,725)
Treasury stock, beginning balance (in shares) at Dec. 31, 2025           (2,661,000)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation 16,670   16,670        
Exercise of stock options (in shares)   121,000          
Exercise of stock options 1,968   1,968        
Common stock - restricted stock units vesting (in shares)   1,043,000          
Common stock - restricted stock units vesting 1 $ 1          
Issuance of common stock, net of issuance costs (in shares)   2,016,000          
Issuance of common stock, net of issuance costs 116,607 $ 2 116,605        
Issuance of pre-funded warrants 99,998   99,998        
Purchase of Capped Calls related to the 2026 Convertible Note (47,880)   (47,880)        
Foreign currency translation adjustments 990     990      
Unrealized gains (losses) on available-for-sale securities, net (6,934)     (6,934)      
Change in ownership interest in consolidated VIE 0   (3,120) (13)     3,133
Gain on VIE's sale of IPR&D assets (7,629)           (7,629)
Net income (loss) (137,572)       (132,732)   (4,840)
Common stock, ending balance (in shares) at Mar. 31, 2026   143,232,000          
Ending balance at Mar. 31, 2026 598,916 $ 236 2,395,267 742 (1,729,075) $ (53,193) (15,061)
Treasury stock, ending balance (in shares) at Mar. 31, 2026           (2,661,000)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation 14,872   14,872        
Exercise of stock options (in shares)   149,000          
Exercise of stock options 5,697   5,697        
Common stock - restricted stock units vesting (in shares)   48,000          
Issuance of common stock, net of issuance costs (in shares)   367,000          
Issuance of common stock, net of issuance costs 27,239 $ 1 27,238        
Foreign currency translation adjustments 487     278     209
Unrealized gains (losses) on available-for-sale securities, net (2,254)     (2,254)      
Net income (loss) $ (178,916)       (194,280)   15,364
Common stock, ending balance (in shares) at Jun. 30, 2026 141,135,000 143,796,000          
Ending balance at Jun. 30, 2026 $ 466,041 $ 237 $ 2,443,074 $ (1,234) $ (1,923,355) $ (53,193) $ 512
Treasury stock, ending balance (in shares) at Jun. 30, 2026 (2,661,000)         (2,661,000)